Skip to main content

Find Clinical Trials

Home
Conditions
Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency

Clinical trial condition

Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency

Explore clinical trials studying Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency trial results

Not Yet Recruiting

QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)

NCT07113964

Conditions: Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details